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Summary 24	  
The Shigella flexneri IcsA (VirG) protein is a polarly distributed autotransporter protein. 25	  
IcsA functions as a virulence factor by interacting with the host actin regulatory protein, N-26	  
WASP, which in turn activates the Arp2/3 complex, initiating actin polymerisation. 27	  
Formation of F-actin comet tails allows bacterial cell-to-cell spreading. Although various 28	  
accessory proteins such as periplasmic chaperones and the BAM complex have been 29	  
shown to be involved in the export of IcsA, the IcsA translocation mechanism remains to 30	  
be fully elucidated. A putative autochaperone (AC) region (aa 634-735) located at the C-31	  
terminal end of the IcsA passenger domain, which forms part of the self-associating 32	  
autotransporter (SAAT) domain, has been suggested to be required for IcsA biogenesis, 33	  
as well as for N-WASP recruitment, based on mutagenesis studies. IcsAi proteins with 34	  
linker insertion mutations within the AC region have a significant reduction in production 35	  
and are defective in N-WASP recruitment when expressed in smooth lipopolysaccharide 36	  
(S-LPS) S. flexneri. In this study, we have found that the LPS O-antigen (Oag) play a role 37	  
in IcsAi production based on use of an rmlD (rfbD) mutant having rough LPS (R-LPS), and 38	  
a novel assay in which Oag is depleted using tunicamycin treatment and then 39	  
regenerated. In addition, we have identified a new N-WASP binding/interaction site within 40	  
the IcsA AC region. 41	  
 42	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Introduction 43	  
Shigella flexneri is a Gram-negative bacterium that causes bacillary dysentery in humans 44	  
by infecting and colonising the colonic epithelium (Philpott et al., 2000). IcsA (VirG) is an 45	  
essential virulence factor of S. flexneri. It is a polarly distributed 120 kDa outer membrane 46	  
(OM) protein that interacts with N-WASP, resulting in F-actin comet tail formation and 47	  
inter- and intracellular spreading of S. flexneri within the host intestinal epithelium 48	  
(Bernardini et al., 1989; Lett et al., 1989; Makino et al., 1986; Sansonetti et al., 1991; 49	  
Suzuki & Sasakawa, 2001).  50	  
IcsA is a member of the autotransporter (AT) family (Type Va secretion system), the 51	  
largest family of secreted proteins in Gram-negative bacteria (Henderson et al., 2004; 52	  
Pallen et al., 2003). Like other ATs, IcsA is composed of three major domains: an 53	  
extended N-terminal signal sequence (amino acids [aa] 1-52), a functional passenger α-54	  
domain (aa 53-758), and a C-terminal translocation β-domain (aa 759-1102) that mediates 55	  
the translocation of the passenger domain across the OM via the BAM (beta-barrel 56	  
assembly machine) complex (Brandon et al., 2003; Henderson et al., 2004; Jain & 57	  
Goldberg, 2007; Peterson et al., 2010; Suzuki et al., 1995). The involvement of the BAM 58	  
complex and periplasmic chaperones such as DegP, Skp and SurA in IcsA translocation 59	  
suggest that the term ‘autotransporter’ is no longer applicable (Ieva & Bernstein, 2009; 60	  
Jain & Goldberg, 2007; Purdy et al., 2007; Sauri et al., 2009; Sklar et al., 2007; Wagner et 61	  
al., 2009). A common feature of AT proteins is that the exported passenger domain can be 62	  
cleaved and released into the external milieu or remain associated on the bacterial surface 63	  
(Henderson et al., 2004). In S. flexneri, IcsP (SopA) is a virulence plasmid encoded serine 64	  
OM protease that cleaves surface IcsA at the Arg758-Arg759 bond position, releasing a 65	  
~85 kDa IcsA fragment into the culture supernatant (d'Hauteville et al., 1996; Fukuda et 66	  
al., 1995; Steinhauer et al., 1999). In spite of the diversity in sequence, function and 67	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length, the passenger domains of most ATs possess a β-helical structure (Wells et al., 68	  
2010). 69	  
IcsA has recently been classified as a member of the self-associating AT (SAAT) family, 70	  
together with other Escherichia coli ATs such as Ag43, AIDA-1, TibA and Haemophilus 71	  
influenzae Hap that mediate bacterial aggregation and biofilm formation (Klemm et al., 72	  
2006; Meng et al., 2011). In addition, a putative autochaperone (AC) region at the C-73	  
terminal of the IcsA passenger domain (aa 634-735), which is part of the self-associating 74	  
domain, has been proposed to be required for IcsA biogenesis (May & Morona, 2008; 75	  
Meng et al., 2011). The AC region is well conserved among many ATs and is essential for 76	  
AT secretion, folding and/or stability (May & Morona, 2008; Oliver et al., 2003a; Oliver et 77	  
al., 2003b; Yen et al., 2008). While the crystal structure of the full length IcsA passenger 78	  
domain is not yet available, the IcsA AC region crystal structure (aa 591-758) has been 79	  
determined at 2.0-Å resolution and features two coils of a right-handed parallel β-helix 80	  
(Kuhnel & Diezmann, 2011). May & Morona (2008) have previously suggested that the 81	  
IcsA AC region is also an N-WASP interacting region (N-WASP IR III), based on linker-82	  
insertion mutagenesis. 83	  
Lipopolysaccharide (LPS) is a major constituent of the Gram-negative bacteria OM and is 84	  
comprised of lipid A that is anchored into the OM, the core sugar region and the O-antigen 85	  
(Oag) polysaccharide repeat units that extends from the bacterial surface (Raetz & 86	  
Whitfield, 2002). The intact LPS molecules are known as smooth LPS (S-LPS), while LPS 87	  
molecules lacking the Oag, due to mutations affecting either the biosynthesis of Oag 88	  
repeat units (eg. rmlD/rfbD) or their linkage to the core sugars, are known as rough LPS 89	  
(R-LPS) (Van Den Bosch et al., 1997). LPS molecules are synthesised at the inner 90	  
membrane, and current models for the LPS biosynthesis pathway involve the MsbA ABC 91	  
transporter and the LPS transport (Lpt) pathway (Narita & Tokuda, 2009; Raetz & 92	  
Whitfield, 2002; Ruiz et al., 2008; Ruiz et al., 2009; Sperandeo et al., 2008; Tran et al., 93	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2010). S. flexneri LPS has been suggested to be required to reinforce IcsA polar 94	  
localisation and mask laterally located IcsA proteins (Morona & Van Den Bosch, 2003; 95	  
Robbins et al., 2001; Sandlin et al., 1995). However, the effect of LPS Oag in IcsA 96	  
translocation across the OM and its interaction with IcsA have not been reported. 97	  
The role of the IcsA putative AC/SAAT domain has not yet been fully investigated but we 98	  
have previously shown via linker-insertion mutagenesis that this region may play a role in 99	  
IcsA biogenesis (May & Morona, 2008). The production of AC IcsAi (with insertion 100	  
mutations within the AC region) is significantly reduced in the S-LPS S. flexneri strain and 101	  
the strains were defective in recruiting N-WASP. In this study, we analysed the IcsAi 102	  
production in both S-LPS and R-LPS S. flexneri to investigate the role of the AC 103	  
region/SAAT domain in IcsA biogenesis and N-WASP recruitment. We found that LPS 104	  
Oag affects the production of IcsAi. Tunicamycin was used to suppress Oag synthesis, 105	  
and this restored IcsAi production. Hence, Oag synthesis directly impacts IcsAi biogenesis. 106	  
In addition, we investigated the mechanism underlying this and found that DegP protease 107	  
activity contributed to lack of IcsAi production in the S-LPS background. Finally, we 108	  
identified a new N-WASP binding/interaction site within the previously identified N-WASP 109	  
IR III (aa 508-730).  110	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Methods 111	  
Bacterial strains and plasmids 112	  
The strains and plasmids used in this study are listed in Table 1. 113	  
 114	  
Growth media and growth conditions 115	  
All strains used in this study were routinely grown in Luria Bertani (LB). S. flexneri strains 116	  
were grown from a Congo Red positive colony except virulence plasmid-cured strains as 117	  
previously described (Morona et al., 2003). Bacterial cultures were cultured for 18 h, 118	  
diluted 1:20 and grown to mid-exponential phase (2 h) with aeration at 37°C (unless 119	  
otherwise stated). Where appropriate, antibiotics were used at the following 120	  
concentrations: ampicillin (Ap, 100 µg mL-1), chloramphenicol (Cm, 25 µg mL-1), 121	  
kanamycin (Km, 50 µg mL-1), streptomycin (Sm, 100 µg mL-1) or tetracycline (Tet, 10 µg 122	  
mL-1). 123	  
 124	  
DNA methods 125	  
E. coli K-12 DH5α was used for all cloning. DNA manipulation, PCR, transformation and 126	  
electroporation into S. flexneri were performed as previously described (Baker et al., 1999; 127	  
Morona et al., 1995).  128	  
 129	  
Construction of pBAD33::icsP 130	  
The icsP gene was amplified by PCR from S. flexneri 2457T chromosomal DNA (GenBank 131	  
#AF386526) using primers (ET22/ET25) with KpnI and HindIII restriction sites (Table S1). 132	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The purified PCR product was subsequently cloned into the pBAD33 vector using the KpnI 133	  
and HindIII restriction sites. 134	  
 135	  
Antibodies and antisera 136	  
Affinity purified rabbit polyclonal antibody to IcsA was produced as previously described 137	  
(Van Den Bosch et al., 1997). The anti-IcsA antibody was used at 1:100 in 138	  
immunofluorescence (IF) assay or 1:1000 in Western immunoblotting (WB). The rabbit 139	  
polyclonal anti-Skp (1:6000), rabbit polyclonal anti-SurA (1:10,000) and rabbit polyclonal 140	  
anti-MBP-DegP antibodies are generous gifts from Thomas Silhavy (Princeton University), 141	  
Carol Gross (UCSF) and Michael Ehrmann (University of Duisburg-Essen), respectively. 142	  
Affinity purified rabbit polyclonal anti-IcsP antibody (1:1000) was produced by immunising 143	  
a rabbit with purified IcsP-His6 protein. The protein was overexpressed in E. coli M15 144	  
containing pREP4 and IPTG-inducible pQE60-icsP. This plasmid was constructed by 145	  
cloning the icsP gene, which was PCR amplified from 2457T chromosomal DNA 146	  
(GenBank #AF386526) using primers (ET9/ET10) with NcoI and BamHI restriction sites 147	  
(Table S1), and cloned into the corresponding sites in pQE60 (Qiagen). 148	  
 149	  
IcsP protein induction 150	  
18 h bacterial cultures were diluted 1:20 into 10 mL LB supplemented with 0.3% (w/v) 151	  
glucose and grown to mid-exponential phase with aeration at 37°C. Bacterial cultures were 152	  
centrifuged (2,200 xg, 10 min), the supernatant was discarded and cells were washed 153	  
twice with fresh LB prior to resuspension in 10 mL LB. Cultures were divided into 5 mL 154	  
aliquots, 0.3% (w/v) glucose (final concentration) was added into one aliquot as the no 155	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IcsP expression control, while 0.2% (w/v) L-arabinose (final concentration) was added into 156	  
another aliquot to induce IcsP expression for 1 h at 37°C. 157	  
 158	  
Preparation of whole cell lysate 159	  
The equivalent of 5x108 bacteria were centrifuged (2,200 xg, 2 min), resuspended in 100 160	  
µL of 1x sample buffer (Lugtenberg et al., 1975), and heated at 100°C for 5 min prior to 161	  
SDS-PAGE. 162	  
 163	  
TCA precipitation of culture supernatant 164	  
TCA precipitation of culture supernatant was performed as described previously (May & 165	  
Morona, 2008). The equivalent of 5x108 bacteria were centrifuged, and the supernatant 166	  
was treated with 5% (w/v) ice-cold trichloroacetic acid (TCA), and incubated on ice. The 167	  
TCA precipitate was then collected by centrifugation (40,000 xg, 30 min, 4°C), and the 168	  
pellet washed with ice-cold acetone prior to recentrifugation for 5 min. The pellet was air-169	  
dried, resuspended in 100 µL of 1x sample buffer, and heated at 100°C for 5 min prior to 170	  
SDS-PAGE. 171	  
 172	  
Western transfer and detection 173	  
Western immunoblotting was performed as described previously (May & Morona, 2008) 174	  
with some modifications. Briefly, proteins were separated on SDS-7.5%, 12% or 15%-175	  
PAGE gels and transferred to a nitrocellulose membrane. The membrane was blocked 176	  
with 5% (w/v) skim milk in TTBS (Tris-buffered saline, 0.005% (v/v) Tween-20) for 20 min 177	  
and incubated with desired primary antibody in TTBS containing 2.5% (w/v) skim milk for 178	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18 h. After three washes in TTBS, the membrane was incubated with horseradish 179	  
peroxidise-conjugated goat anti-rabbit secondary antibody (Biomediq DPC) for 2 h, 180	  
followed by three washes in TTBS, then three times in TBS. The membrane was incubated 181	  
with CPS3 chemiluminescence substrate (Sigma) for 5 min, followed by exposure of the 182	  
membrane to X-ray film (Agfa). The film was developed using a Curix 60 automatic X-ray 183	  
film processor (Agfa) or imaged with a Kodak Image Station 4000MM Pro (Carestream 184	  
Molecular Imaging) to visualise the reactive bands. 185	  
 186	  
Trypsin accessibility assay 187	  
Limited proteolysis was performed as described previously (May & Morona, 2008; Oliver et 188	  
al., 2003b) with modifications. The equivalent of 5 x109 bacteria were centrifuged, the 189	  
supernatant discarded, and the pellet resuspended in 250 µL PBS. Bacterial suspensions 190	  
were then treated with 0.1 µg trypsin mL-1 (from bovine pancreas; Roche) and incubated at 191	  
25°C to allow proteolysis. Aliquots were taken at different time points (0 min, 5 min, 15 min 192	  
and 20 min) and supplemented with 1 mM phenylmethylsulphonyfluoride (PMSF; Sigma) 193	  
to inhibit further proteolysis by trypsin. An equal volume of 2x sample buffer was added to 194	  
each sample, heated at 100 °C for 5 min prior to SDS-PAGE and Western immunoblotting 195	  
or storage at -20 °C. 196	  
 197	  
LPS and silver staining 198	  
LPS samples were prepared as previously described (Murray et al., 2003; Tsai & Frasch, 199	  
1982). Briefly, the equivalent of 1x109 bacteria were centrifuged (2,200 xg, 2 min), 200	  
resuspended in 50 µL lysing buffer (Papadopoulos & Morona, 2010) and incubated with 201	  
2.5 µg proteinase K mL-1 (Invitrogen) for 16 h at 56°C. The LPS samples were 202	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electrophoresed on a SDS-15%-PAGE gel for 16-18 h at 12 mA, and the gel was stained 203	  
with silver nitrate and developed with formaldehyde (Murray et al., 2003). 204	  
 205	  
LPS depletion-regeneration assay 206	  
18 h bacterial cultures were diluted 1:20 into LB and grown to mid-exponential phase with 207	  
aeration at 37°C. The bacterial strains were further diluted 1:20 into LB supplemented with 208	  
3 µg polymyxin B nonapeptide mL-1 (PBMN; Sigma) and 10 µg tunicamycin mL-1 (Sigma) 209	  
in DMSO, and treated for 3 h with aeration at 37°C (depletion phase). Bacterial cultures 210	  
were then centrifuged, washed twice with fresh LB to remove PMBN and tunicamycin 211	  
residues, and further diluted 1:20 into LB prior to additional incubation at 37°C with 212	  
aeration for another 3 h (regeneration phase). Samples were prepared for LPS analysis 213	  
and Western immunoblotting.  214	  
 215	  
Construction of a S. flexneri ΔicsA degP::Cm mutant strain 216	  
The construction of S. flexneri ΔicsA degP::Cm mutant strain was performed as previously 217	  
described (Purins et al., 2008). pRMA2802 [pCVD442-degP::Cm] was conjugated into 218	  
RMA2041, and sucrose/Cm/Tet-resistant and Ap-sensitive colonies were isolated and 219	  
named MYRM522. The degP::Cm mutation was confirmed by Western immnublotting and 220	  
a temperature sensitivity phenotype. 221	  
 222	  
Site-directed mutagenesis 223	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Site-directed mutagenesis was performed according to the QuikChange® Lightning Site-224	  
directed protocol (Stratagene). Specific primers with the desired substitutions were 225	  
designed (Table S1). Mutations were confirmed by DNA sequencing. 226	  
 227	  
Construction of the icsA-TGA-lacZ reporter 228	  
The PstI flanked lacZ-Km fragment from pKOK6.1 (Kokotek & Lotz, 1989; Murray et al., 229	  
2003) was digested with PstI and ligated into the compatible NsiI site of pIcsA (Van Den 230	  
Bosch & Morona, 2003) (nt 221623 and nt 225138, GenBank #AF386526) to give the 231	  
PicsA-lacZ construct, pMYRM632. The transcriptional PicsA-TGA-lacZ reporter plasmid 232	  
was created by mutating an amino acid between the icsA sequence and lacZ sequence of 233	  
PicsA-lacZ into a stop codon (TGA) via site-directed mutagenesis, as described above, 234	  
with primer pairs listed in Table S1. The resultant construct was named pMYRM676. The 235	  
PstI-SalI fragment from pMYRM676 which contains the PicsA-TGA-lacZ fragment, was 236	  
subsequently cloned into the likewise digested pSU23 vector to obtain the transcriptional 237	  
reporter plasmid, pMYRM718. 238	  
 239	  
β-galactosidase assay 240	  
The β-galactosidase assay was performed using the Miller protocol (Miller, 1972) with 241	  
some modifications. 18 h bacterial cultures were diluted 1:20 into 10 mL LB and grown to 242	  
mid-exponential phase with aeration at 37°C. The OD600 of bacterial culture was 243	  
measured, 1 mL sample was taken, centrifuged, the supernatant discarded and the pellet 244	  
resuspended in Z buffer. Cells were permeabilised by adding 20 µL 0.1% (w/v) SDS and 245	  
40 µL chloroform and mixed vigorously for 10 sec. 120 µL samples were dispensed into a 246	  
96 well microtitre tray in triplicates and 24 µL 7 mg ortho-Nitrophenyl-β-galactoside mL-1 247	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(ONPG) was added into each well. Samples were incubated at 37°C for 3 h and readings 248	  
(OD420 and OD550) were taken at 2 min intervals. Units of activity were calculated as 249	  
previously described (Miller, 1972).  250	  
 251	  
Indirect immunofluorescence of whole bacteria 252	  
Indirect IF labelling of bacteria was performed as described previously (May & Morona, 253	  
2008). Briefly, mid-exponential phase bacteria were fixed in 3.7% (v/v) formalin and 254	  
centrifuged onto poly-L-lysine-coated coverslips. Bacteria were incubated with anti-IcsA 255	  
antibody diluted 1:100 in PBS with 10% (v/v) foetal calf serum (FCS), washed with PBS 256	  
and labelled with Alexa 488-conjugated donkey anti-rabbit secondary antibody (Molecular 257	  
Probes) (1:100). Microscopy was performed using an Olympus IX-70 microscope with 258	  
phase-contrast optics using a 100x oil immersion objective. Fluorescence and phase-259	  
contrast images were false colour merged using the Metamorph software program 260	  
(Version 7.7.3.0, Molecular Devices). 261	  
 262	  
Infection of tissue culture monolayers with S. flexneri and IF labelling 263	  
Infection of HeLa cell monolayers and IF staining were performed as described previously 264	  
(May & Morona, 2008). Briefly, HeLa monolayers were inoculated with mid-exponential 265	  
phase bacteria and incubated for 1 h at 37°C, 5% CO2. The infected monolayers were 266	  
washed three times with D-PBS and incubated with MEM containing gentamycin for a 267	  
further 1.5 h. Infected cells were then washed and fixed for 15 min in 3.7% (v/v) formalin, 268	  
incubated with 50 mM NH4Cl in D-PBS for 10 min, and permeabilised with 0.1% (v/v) 269	  
Triton X-100 for 5 min. The infected cells were blocked with 10% (v/v) FCS in PBS and 270	  
incubated with anti-N-WASP antibody. After washing in PBS, coverslips were incubated 271	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with Alexa Fluor 594-conjugated donkey anti-rabbit secondary antibody (Molecular 272	  
Probes) (1:100). F-actin was visualised by staining with Alexa Fluor 488-conjugated 273	  
phalloidin (2 U mL-1), and 4’,6’-diamidino-2-phenylindole (DAPI) (10 µg ml-1) was used to 274	  
counterstain bacteria and cellular nuclei. 275	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Results 276	  
IcsAi mutant production is restored in S. flexneri ∆icsA ΔrmlD 277	  
LPS is known to mask surface IcsA function (Morona et al., 2003; Morona & Van Den 278	  
Bosch, 2003). May & Morona (2008) also reported that S-LPS can affect N-WASP 279	  
recruitment and F-actin comet tail formation, by expressing certain IcsAi (outside the AC 280	  
region) and IcsA deletion mutants in a R-LPS S. flexneri strain. Hence, four previously 281	  
identified IcsAi mutants with 5 aa insertion within the AC region (IcsAi633, IcsAi643, IcsAi677, 282	  
and IcsA716) which had defects in protein production and N-WASP recruitment when 283	  
expressed in S. flexneri ΔicsA S-LPS (RMA2041) (May & Morona, 2008), were re-284	  
examined in this study. The mutants were expressed in S. flexneri ΔicsA ΔrmlD R-LPS 285	  
strain (RMA2043) and the IcsAi protein production was assessed by Western 286	  
immunoblotting. 287	  
As previously reported, IcsAi633, IcsAi643 and IcsAi677 were poorly detected while IcsAi716 288	  
could not be detected when expressed in S. flexneri ΔicsA S-LPS strain (Fig. 1a, lanes 3, 289	  
5, 7 and 9). Surprisingly, IcsAi mutant production in S. flexneri ΔicsA ΔrmlD R-LPS strain 290	  
was restored to a near wild-type (WT) levels (Fig. 1a, lanes 4, 6, 8, and 10), which were 291	  
consistent with the results obtained by IF microscopy (Fig. 1b). IcsAi716 protein expression 292	  
on the surface of S. flexneri ΔicsA strain was poorly detectable (Fig. 1b(iii)), in comparison 293	  
to the high level of IcsAi716 detected on S. flexneri ΔicsA ΔrmlD strain (Fig. 1b(iv)); it was 294	  
also noted that IcsAi716 has a polar localisation, like IcsAWT (Fig. 1b(i,ii)). Similar results 295	  
were obtained for IcsAi633, IcsAi643, and IcsAi677 (data not shown). IcsA staining was not 296	  
observed for RMA2041 (ΔicsA) and RMA2043 (ΔicsA ΔrmlD), indicating the anti-IcsA 297	  
antibody is specifically targeting the IcsA protein (Fig. 1b(v,vi)).  298	  
 299	  
rmlD complementation  300	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The rmlD (also known as rfbD) gene encodes for dTDP-6-deoxy-L-mannose 301	  
dehydrogenase which is involved in the synthesis of the nucleotide sugar dTDP-rhamnose 302	  
that is the precursor for rhamnose in the S. flexneri Oag repeat units (Reeves et al., 1996). 303	  
To determine if the effect of rmlD on the IcsAi expression is directly related to the 304	  
ΔrmlD::Km mutation, S. flexneri ΔicsA ΔrmlD R-LPS strains expressing either IcsAWT, or 305	  
various IcsAi were complemented with rmlD carried by pRMA727. As a control, the same 306	  
S. flexneri strains were transformed with the empty vector, pACYC184. The LPS profile 307	  
and IcsA production of the resultant strains was subsequently determined. S. flexneri 308	  
ΔrmlD strains were successfully complemented by pRMA727 which restored their S-LPS 309	  
profile (Fig. 2a, lanes 2, 4, 6, 8 and 10), while strains that were transformed with 310	  
pACYC184 retained their R-LPS profile (Fig. 2a, lanes 1, 3, 5, 7 and 9). As seen in Fig. 2b, 311	  
rmlD complementation also reverted IcsAi production to very low level as seen in the S-312	  
LPS background, compared to the R-LPS strains. IcsAWT production remained unaffected 313	  
in both S-LPS and R-LPS backgrounds. In another experiment, very low levels of IcsAi 314	  
production was also observed in the E. coli K-12 ompT– UT5600 strains that were 315	  
complemented to produce S-LPS but had higher IcsAi protein expression in the R-LPS 316	  
background (Fig. S1). Hence, the presence and absence of Oag chains results in an 317	  
inverse IcsAi production in both S. flexneri and E. coli K-12 ompT– strain backgrounds. 318	  
 319	  
Effect of LPS Oag modulation on IcsAi716 mutant production 320	  
The rmlD complementation assay showed that LPS Oag synthesis affects IcsAi mutant 321	  
production in S. flexneri. To independently verify the effect of LPS Oag on IcsAi mutant 322	  
production, a novel LPS Oag depletion-regeneration assay was developed, as described 323	  
in the Methods, and performed on a S. flexneri ΔicsA strain expressing either IcsAWT or 324	  
IcsAi716. Tunicamycin was used at a concentration of 10 µg mL-1 (in DMSO) in conjunction 325	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with 3 µg polymyxin B nonapeptide mL-1 (PMBN) to inhibit Oag biosynthesis. The 326	  
subsequent removal of tunicamycin and PMBN resulted in regeneration of Oags. 327	  
Tunicamycin is a nucleoside antibiotic that inhibits the WecA enzyme (N-328	  
acetylglucosamine-1-phosphate transferase) which is involved in the first step of Oag 329	  
biosynthesis (Alexander & Valvano, 1994; Brandish et al., 1996). PMBN is a non-toxic 330	  
peptide derivative of polymyxin B which helps to permeabilise the OM of Gram-negative 331	  
bacteria and facilitates the entry of hydrophobic tunicamycin into the bacterial cell (Vaara 332	  
& Vaara, 1983; Vaara, 1992). LPS silver staining showed that Oag biosynthesis was 333	  
significantly inhibited by approximately 90% after 3 h of treatment with tunicamycin/PMBN 334	  
(Fig. 3a, lanes 2 and 7), while the Oag production was restored upon the removal of 335	  
tunicamycin/PMBN (Fig. 3a, lanes 3 and 8). Oag biosynthesis in strains treated with 336	  
DMSO only (negative control) remained unchanged (Fig. 3a, lanes 4-5 and 9-10, 337	  
respectively).  338	  
Western immunoblotting showed that IcsAWT protein was produced regardless of the 339	  
tunicamycin/PMBN treatment (Fig. 3b, lanes 1-5). In contrast, while IcsAi716 mutant 340	  
production was hardly detectable when the strain was untreated (Fig. 3b, lane 6) or treated 341	  
with DMSO (Fig. 3b, lanes 9-10), a full length 120 kDa IcsAi716 band was readily detected 342	  
when the LPS Oag biosynthesis was inhibited (Fig. 3b, lane 7). As expected, the IcsAi716 343	  
band was no longer detectable when the LPS Oags were regenerated (Fig. 3b, lane 8). 344	  
Overall, these results indicate that LPS Oags affect IcsAi mutant production in the S-LPS 345	  
S. flexneri. The potential mechanism(s) involved were investigated as described below.  346	  
 347	  
Effect of IcsP on IcsAi expression in S-LPS and R-LPS S. flexneri 348	  
The locations of the 5 aa linker-insertion mutations in the IcsA AC region are in close 349	  
proximity to the IcsP cleavage site (aa 758-759). Therefore, we hypothesised that the IcsP 350	  
	   17	  
cleavage site of IcsAi may be altered and/or became more accessible to IcsP which may 351	  
cleave IcsAi more readily in the S-LPS background. To test our hypothesis, IcsAi716 was 352	  
selected and the amount of IcsA’ protein (cleaved form) in the culture supernatants of both 353	  
S-LPS and R-LPS backgrounds was investigated. The cleaved form of IcsAi716 was not 354	  
detected in the S-LPS background (Fig. 4a, lane 6) but was observed in the R-LPS 355	  
background (Fig. 4a, lane 8), at a similar level to that seen for IcsAWT protein in both 356	  
backgrounds (Fig. 4a, lanes 2 and 4).  357	  
We also investigated the effect of the presence and absence of IcsP in virulence plasmid-358	  
cured (VP-ve) S-LPS and R-LPS backgrounds. Results consistent with the above were 359	  
obtained when various IcsAi proteins were expressed in VP-ve S-LPS and VP-ve R-LPS S. 360	  
flexneri strain carrying pBAD33::icsP. IcsAi production in S. flexneri VP- S-LPS remained 361	  
extremely low and was not restored to IcsAWT levels despite the absence of IcsP (Fig. 4b). 362	  
In contrast, S. flexneri VP- R-LPS background showed production of IcsAi proteins at WT 363	  
level (except IcsAi634 which showed slightly lower levels of protein production than IcsAWT) 364	  
when IcsP was absent (Fig. 4c). Interestingly, the IcsAi proteins appeared to be more 365	  
sensitive to IcsP cleavage than IcsAWT as a reduction in the full length IcsAi mutant 366	  
proteins (120 kDa) was observed when IcsP was induced (Fig. 4c, lanes 4, 6, 8, and 10). 367	  
The IcsAi643 mutant in particular, appeared to be more sensitive to IcsP cleavage 368	  
compared to the other IcsAi proteins (Fig. 4c, lane 6). The levels of the cleaved form of 369	  
IcsAi’ (85 kDa) that remained associated with bacterial cells were comparable to IcsA’WT 370	  
(Fig. 4c). These data suggest that IcsP does not have a major role in reducing IcsAi 371	  
production in the S-LPS background and most IcsAi proteins are more sensitive to IcsP 372	  
cleavage than IcsAWT, possibly due to a change in protein conformation. 373	  
 374	  
icsA promoter activity 375	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To determine if the icsA promoter activity is upregulated in the R-LPS background and 376	  
contributing to the high IcsAi mutant expression level, we created a transcriptional reporter 377	  
plasmid pMYRM718 [PicsA-TGA-lacZ], encoding an icsA promoter fusion with lacZ in 378	  
pSU23, as described in the Methods. Both S-LPS and R-LPS S. flexneri strains carrying 379	  
either pIcsAWT or pIcsAi716 were transformed with pMYRM718, to give strains MYRM734 380	  
(S-LPS + pIcsAWT + PicsA-TGA-lacZ), MYRM721 (R-LPS + pIcsAWT + PicsA-TGA-lacZ), 381	  
MYRM722 (S-LPS + pIcsAi716 + PicsA-TGA-lacZ) and MYRM723 (R-LPS + pIcsAi716 + 382	  
PicsA-TGA-lacZ), respectively. Each strain was grown to mid-exponential phase and β-383	  
galactosidase levels were assayed. LacZ activity was measured in the presence of either 384	  
IcsAWT or IcsAi716 because the presence of a misfolded protein might create a feedback 385	  
loop to activate icsA promoter activity or gene expression. The data show that there was 386	  
no significant difference in icsA promoter activity between MYRM734 and MYRM721 (in 387	  
the presence of IcsAWT), while the icsA promoter activity was slightly higher in MYRM722 388	  
than MYRM723 (in the presence of IcsAi716) (*P < 0.5) (Fig. 5). The data suggest that the 389	  
very low IcsAi protein production in the S-LPS background is unlikely due to an effect of 390	  
transcriptional level, but may be due to a post-transcriptional effect, such as increased 391	  
proteolysis. 392	  
 393	  
IcsAi716 mutant production in a S. flexneri degP::Cm ΔicsA S-LPS strain 394	  
Since the OM protease, IcsP, did not appear to cause the low IcsAi mutant production in 395	  
S-LPS S. flexneri, we hypothesised that the translocation of IcsAi-periplasmic intermediate 396	  
across the OM is retarded in such a way that prolonged exposure to periplasmic 397	  
proteases, such as DegP, degrades the IcsAi-periplasmic intermediate. DegP is a 398	  
temperature regulated bifunctional periplasmic protein that may act as a chaperone or a 399	  
protease at 37 °C but as a chaperone at low temperature (Spiess et al., 1999). A S-LPS S. 400	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flexneri degP::Cm ΔicsA mutant strain was created as described in the Methods and the 401	  
strain was subsequently complemented with pIcsAWT or pIcsAi716. The resultant strains 402	  
expressing either IcsAWT or IcsAi716 were grown to mid-exponential phase at 30°C or 37°C 403	  
and the production of IcsA was assessed by Western immunoblotting. Protein production 404	  
of IcsAi716 was partly restored in the ΔdegP background at both 30°C and 37°C (Fig. 6, 405	  
lanes 5 and 6), in comparison to IcsAWT (Fig. 6, lanes 3 and 4). The data suggest that in 406	  
the presence of LPS Oag, DegP protease is largely responsible for degrading the IcsAi 407	  
mutant protein.  408	  
 409	  
Expression of DegP, Skp and SurA periplasmic chaperones in S-LPS and R-LPS S. 410	  
flexneri 411	  
The expression of periplasmic chaperones such as DegP, Skp and SurA are regulated by 412	  
the σE envelope stress response or the Cpx two-component signal transduction system 413	  
(Duguay & Silhavy, 2004; Raivio & Silhavy, 2001; Rhodius et al., 2006). In comparison to 414	  
a S. flexneri ∆icsA S-LPS strain, the S. flexneri ∆icsA ∆rmlD R-LPS strain (which has the 415	  
rmlD gene deleted) might be under stress and hence, may have upregulated periplasmic 416	  
chaperone expression. Therefore, the expression level of DegP, Skp and SurA in both S-417	  
LPS and R-LPS S. flexneri (in the presence or absence of IcsAWT or IcsAi716), were 418	  
examined. The production of DegP, Skp and SurA was not upregulated in the R-LPS 419	  
background (Fig. S2) even in the presence of IcsAi716 protein, indicating a lack of cell 420	  
envelope stress response. However, this does not exclude that their chaperone activity is 421	  
not being upregulated in the R-LPS strain. Likewise, DegP proteolysis activity in the S-LPS 422	  
background may be upregulated in the presence of IcsAi mutant protein. 423	  
 424	  
Effect of AC region insertion mutations on IcsAi functionality in S. flexneri ΔicsA ΔrmlD 425	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The N-WASP recruitment ability of various IcsAi AC mutants expressed by R-LPS S. 426	  
flexneri was investigated to determine if the proteins retained their function. R-LPS S. 427	  
flexneri expressing IcsAWT or various IcsAi were used to infect HeLa cells and N-WASP 428	  
recruitment was detected as described in the Methods. Except the IcsAi716 mutant (Fig. 7f), 429	  
IcsAi633, IcsAi643 and IcsAi677 (Fig. 7d) (Data for IcsAi633, IcsAi643 not shown) mutants 430	  
recruited N-WASP and formed F-actin comet tails within HeLa cells, suggesting that 431	  
IcsAi633, IcsAi643 and IcsAi677 have WT protein conformation and are functional. In contrast, 432	  
despite the high level of IcsAi716 protein detected on the bacterial surface of LB grown cells 433	  
(Fig. 1b), neither N-WASP nor F-actin comet tails were detected (Fig. 7f), suggesting that 434	  
an N-WASP binding/interacting site could be located at aa 716-717. Alternatively, IcsAi716 435	  
might be highly misfolded, thus, masking the N-WASP binding/interacting sites and 436	  
inhibiting F-actin comet tail formation. Data for S-LPS S. flexneri expressing IcsAWT, 437	  
IcsAi677, and IcsAi716 are shown for comparison (Fig. 7a, c and e).  438	  
 439	  
Potential effect of insertion mutations on IcsAi protein folding  440	  
As the 5 aa linker-insertion mutations might result in altered IcsAi protein conformations 441	  
and affect N-WASP recruitment ability, the protein conformation of IcsAi was investigated. 442	  
S. flexneri ΔicsA ΔrmlD expressing either IcsAWT or IcsAi were subjected to 1 µg trypsin 443	  
mL-1 over a period of time (0 min, 5 min, 15 min and 20 min). A misfolded protein could be 444	  
more sensitive to trypsin degradation, giving a different proteolysis profile than IcsAWT in 445	  
Western immunoblotting. The results of limited proteolysis assay (Fig. 8) suggest that all 446	  
tested IcsAi mutants do not have major difference to the IcsAWT profile. In spite of the 447	  
similar proteolysis profiles, IcsAi643 and IcsAi716 seem to be more sensitive to trypsin 448	  
degradation, as the overall IcsA band profile intensity for these IcsAi mutants was 449	  
significantly reduced after 15 min of trypsin digestion (Fig. 8, lanes 11 and 19), whilst 450	  
IcsAi633 and IcsAi677 had a WT proteolysis profile (Fig. 8, lanes 5-8 and 13-16, 451	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respectively). The data suggest that the IcsAi mutants do not have major change in 452	  
conformation. Furthermore, our laboratory has recently shown that the S. flexneri IcsA 453	  
protein is able to self-associate and form a complex in the OM (May et al., 2012). Thus, 454	  
DSP chemical cross-linking was performed to examine if the IcsAi mutants retain their self-455	  
association ability. The results showed that all tested IcsAi mutants formed high molecular 456	  
weight proteins like IcsAWT (data not shown), indicating that the mutants possess WT 457	  
protein conformation, which is consistent with the results obtained from the trypsin 458	  
accessibility assay, and the ability to recruit N-WASP (except for IcsAi716). 459	  
 460	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Discussion 461	  
The IcsA (VirG) protein of S. flexneri is a Type Va autotransporter protein (Henderson et 462	  
al., 2004) that allows S. flexneri to spread between the host intestinal epithelial cells 463	  
(Bernardini et al., 1989; Goldberg et al., 1993; Goldberg, 2001; Lett et al., 1989). IcsA 464	  
hijacks the host actin regulatory protein, N-WASP, and forms F-actin comet tails at one 465	  
pole of the bacterium that propel Shigella in the opposite direction (Bernardini et al., 1989; 466	  
Brandon et al., 2003).  467	  
The translocation mechanism of various OMPs or ATs has been studied extensively in E. 468	  
coli (Ieva et al., 2011; Peterson et al., 2010; Ruiz-Perez et al., 2010; Soprova et al., 2010; 469	  
Walton et al., 2009). However, the detailed mechanisms of IcsA biogenesis have not been 470	  
fully elucidated. In this study, N-WASP recruitment ability and the role of the AC region in 471	  
IcsA biogenesis was investigated in both S-LPS and R-LPS backgrounds, and differs 472	  
markedly from other studies on AC regions in this regard.  473	  
The restoration of AC IcsAi mutant production in R-LPS S. flexneri allowed us to examine 474	  
N-WASP recruitment ability, and IcsAi716 which possesses 5 aa insertion at the Aro716-X717-475	  
Aro718 motif was identified as defective in N-WASP recruitment. This suggests that either 476	  
residues 716-717 is an N-WASP binding/interaction site, or IcsAi716 is severely misfolded 477	  
and masked the N-WASP binding sites. Both IcsAi643 and IcsAi716 demonstrated a slightly 478	  
increased sensitivity to trypsin degradation but had a proteolysis profile similar to the WT 479	  
(Fig. 8). This could be due to the presence of arginine residue in the inserted 5 aa 480	  
sequence (Table S2), which is a trypsin cleavage site. However, IcsAi643 is able to recruit 481	  
N-WASP despite the increased sensitivity to trypsin. This result implies that any alteration 482	  
in protein conformation is limited. Thus, IcsAi716 which has a similar proteolysis profile to 483	  
IcsAi643 is likely to also possess a near WT conformation.  Moreover, high molecular IcsAi 484	  
complexes were detected in DSP chemical cross-linking (data not shown), and suggests 485	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that all IcsAi AC mutants are able to self-associate and have a conformation similar to WT. 486	  
Taken together, all IcsAi AC mutants do not have major alteration in protein conformation. 487	  
The data also suggest that an N-WASP binding/interacting site is located at residues 716-488	  
717. This has been confirmed by site-directed mutagenesis of aa 716-717, and functional 489	  
complementation of an N-WASP interacting region II mutant IcsA protein (Teh and 490	  
Morona, unpublished data). 491	  
Mutations within the IcsA AC region significantly affected IcsAi production in the S. flexneri 492	  
S-LPS background (May & Morona, 2008) but not in the R-LPS background (Fig. 1). This 493	  
finding was supported by rmlD complementation assay which generated the same 494	  
phenotype (Fig. 2), as well as expression of various IcsAi mutants in the E. coli K-12 495	  
ompT- UT5600 strain (with or without S-LPS) (Fig. S1). These data demonstrate that the 496	  
presence of LPS Oag affects biogenesis of IcsAi proteins with mutations within the AC 497	  
region, independent of S. flexneri-specific virulence determinants, as the IcsAi phenotype 498	  
was reproduced in VP-ve S. flexneri and in UT5600 strain backgrounds. In addition, we 499	  
showed that the very low level of IcsAi production in the S-LPS background was not due to 500	  
extensive IcsP cleavage. Therefore, to directly investigate the effect of LPS Oag on IcsAi 501	  
mutant production, an LPS depletion-regeneration assay was undertaken. We 502	  
demonstrated that the depletion of Oag restored IcsAi mutant production and the effect 503	  
was reversible (Fig. 3). The data suggests that the presence of Oag affects IcsA 504	  
biogenesis in an unknown mechanism and possibly plays an unidentified new role in the 505	  
IcsA translocation system. LPS Oag has never been shown to interact with either the 506	  
exported IcsA or IcsA-periplasmic intermediate. 507	  
Our findings show that the icsA promoter activity was not downregulated in S-LPS S. 508	  
flexneri in the presence of IcsAWT or IcsAi AC mutant, indicating the differences in IcsAi 509	  
production between the S-LPS and R-LPS backgrounds was not due to a general effect on 510	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the transcription of AC IcsAi. These data suggest that a post-transcriptional effect is 511	  
involved in affecting AC IcsAi production in the S-LPS strain background. 512	  
The presence of a transient soluble IcsA-periplasmic intermediate has previously been 513	  
reported (Brandon & Goldberg, 2001) and periplasmic chaperones such as DegP, Skp and 514	  
SurA are required for proper IcsA presentation (Purdy et al., 2002; Purdy et al., 2007). 515	  
DegP which is also a protease was reported to degrade unproductive or misfolded OMPs 516	  
in the periplasm (Kolmar et al., 1996; Soprova et al., 2010). As shown in Fig. 6, IcsAi 517	  
protein production was restored by a ΔdegP mutant in the S-LPS background, suggesting 518	  
that IcsAi-periplasmic intermediate was sensitive to DegP degradation in the presence of 519	  
LPS Oag. In addition, we showed that the DegP expression level (as well as Skp and 520	  
SurA) remained the same between S-LPS and R-LPS backgrounds even in the presence 521	  
of IcsAi AC protein. It is possible that DegP could be less active as a protease in the R-522	  
LPS background or vice versa in the S-LPS background. However, there are no reports of 523	  
DegP having LPS-dependent activity. Hence, it is unclear how S-LPS may be affecting 524	  
DegP and hence, IcsAi AC mutant protein production. 525	  
We speculate that an early interaction occurs between the Skp-IcsAi complex with 526	  
transiting S-LPS or R-LPS molecules in the periplasm, via the putative LPS binding site on 527	  
the outer surface of Skp (Korndorfer et al., 2004; Walton & Sousa, 2004). This interaction 528	  
may promote dissociation of IcsAi from Skp due to a weak interaction caused by the IcsAi 529	  
AC mutations. The released and unprotected IcsAi mutant might then be rapidly 530	  
aggregated and become degraded by DegP. On the other hand, binding of R-LPS 531	  
molecule to the Skp-IcsAi complex would not promote IcsAi dissociation; this could be a 532	  
function of Oag polysaccharide chains. Interestingly, Oag polysaccharides are a substrate 533	  
for bacteriophage tailspike protein (TSP) that have a right-handed parallel β-helix structure 534	  
(Steinbacher et al., 1996) which is similar to the predicted IcsA structure (Kuhnel & 535	  
Diezmann, 2011), and that of other ATs (Emsley et al., 1996; Johnson et al., 2009; Khan 536	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et al., 2011; Otto et al., 2005). Another possibility is that a third unknown factor which is 537	  
affected by Oag is involved in influencing IcsAi interaction with chaperones. Nonetheless, 538	  
this hypothetical model warrants further investigation, as interaction between Skp and LPS 539	  
has not been shown in vivo, and no data suggesting Skp binding to AC region of IcsA 540	  
have been reported. 541	  
Even though IcsAi716 production was restored in the S. flexneri ΔdegP strain, the degree of 542	  
IcsAi716 restoration was not 100% (Fig. 6), and this could be due to the location of the 543	  
insertion mutation. Residue Y716 is part of the Aro-X-Aro motif which is a preferential SurA 544	  
binding site (Bitto & McKay, 2003; Xu et al., 2007) and based on the IcsA AC crystal 545	  
structure, residue Y716 is predicted to be located at the beginning of the first anti-parallel 546	  
β-strand which appears to be exposed to the external medium (Fig. S3). Direct interaction 547	  
between IcsA and SurA has not been reported, and if residues 716-718 were a SurA 548	  
binding site, we speculate that the 5 aa insertion mutation might have altered this potential 549	  
SurA binding site and reduced the chaperone protection from SurA during the 550	  
translocation of IcsA passenger domain across the OM, hence, reducing IcsAi716 551	  
production. Again, the assumption of interaction between SurA and IcsA AC region 552	  
requires further investigations. Alternatively, IcsAi716 could be degraded by other 553	  
periplasmic protease such as DegQ. In comparison, triple Aro-X-Aro motif mutations in the 554	  
E. coli AT EspP passenger domain were required to observe a reduction in the EspP 555	  
secretion (Ruiz-Perez et al., 2009), suggesting that the effect of Aro-X-Aro motif in IcsA is 556	  
more significant than in EspP. 557	  
We have demonstrated for the first time that the presence of LPS Oag affects protein 558	  
production of IcsA. Nevertheless, LPS Oag does not affect IcsAWT biogenesis but affects 559	  
biogenesis of IcsA that has mutational alteration in the AC region, which is a novel finding 560	  
that has never been reported before in IcsA or other autotransporters. As suggested 561	  
above, we speculate that LPS, Skp and SurA interaction with IcsA may be altered by the 562	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AC region mutations, and this remains to be investigated. Collectively, our data suggest an 563	  
alternative role for the AC domain and that it affects interactions with chaperones during 564	  
export. Our findings provide new insights into IcsA biogenesis. In addition, we have 565	  
identified a new N-WASP binding/interaction site within the AC region which narrows down 566	  
the previously reported N-WASP interacting region (aa 508-730) (May & Morona, 2008) 567	  
and this is the subject of further study (Teh and Morona, unpublished data). 568	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Table 1: Bacterial strains and plasmids 887	  
Strain or plasmid Relevant characteristics # Reference or source 
E. coli K-12   
DH5α F-(80dlacZ M15) (lacZYA-argF) U169 hsdR17(r-m+) 
recA1 endA1 relA1 deoR 
Gibco-BRL 
DH5 F-, rec A1, end A1, hod R17 (rk-, mk+), sup E44, 
lambda -, thi 1, gyrA, rel A1 
Laboratory collection 
M15 NaIs Strs Rifs thi- lac- ara+ gal+ mtl- F- recA+ 
uvr+ lon+ 
Qiagen 
S-17 Conjugative strain Laboratory collection 
RMA2802 S-17-1 λ pir [pCVD442 + degP::Cm] (Purins et al., 2008) 
MC4100 F-araD139 A(argF-lac)U169 rpsL150 deoCI relAl 
thiA ptsF25 flbB5301 
(Zalucki & Jennings, 
2007) 
JGS190 MC4100 ara+ ∆skp zae::Tn10 (Sklar et al., 2007) 
MG1655 K-12 (MG1655) rph-1 (Mutalik et al., 2009) 
CAG41291 MG1655 surA::KmR  Carol Gross 
S. flexneri   
2457T S. flexneri 2a wild type Laboratory collection 
RMA2041 2457T ∆icsA::TcR (Van Den Bosch & 
Morona, 2003) 
RMA2090 RMA2041 [pIcsA] (Van Den Bosch & 
Morona, 2003) 
RMA2043 RMA2041 ∆rmlD::KmR (Van Den Bosch & 
Morona, 2003) 
RMA2107 RMA2043 [pIcsA] (Van Den Bosch & 
Morona, 2003) 
RMA2159 Virulence plasmid-cured 2457T  Laboratory collection 
RMA2161 RMA2159 rfbD::KmR Laboratory collection 
KMRM109 RMA2041 [pIcsAi633] (May & Morona, 2008) 
KMRM114 RMA2041 [pIcsAi643] (May & Morona, 2008) 
KMRM134 RMA2041 [pIcsAi677] (May & Morona, 2008) 
KMRM147 RMA2041 [pIcsAi716] (May & Morona, 2008) 
MYRM275 RMA2043 [pIcsAi643] This study	  
MYRM276 RMA2043 [pIcsAi677] This study	  
MYRM277 RMA2043 [pIcsAi716] This study	  
MYRM289 RMA2043 [pIcsAi633] This study	  
MYRM293 RMA2041 [pBR322] This study	  
MYRM294 RMA2043 [pBR322] This study	  
MYRM296 RMA2159 [pBAD33::icsP] This study	  
MYRM297 RMA2161 [pBAD33::icsP] This study	  
MYRM298 MYRM296 [pIcsA] This study	  
MYRM299 MYRM297 [pIcsA] This study	  
MYRM303 MYRM296 [pIcsAi633] This study	  
MYRM304 MYRM296 [pIcsAi643]	   This study	  
MYRM305 MYRM296 [pIcsAi677]	   This study	  
MYRM306 MYRM296 [pIcsAi716]	   This study	  
MYRM310 MYRM297 [pIcsAi633] This study	  
MYRM311 MYRM297 [pIcsAi643]	   This study	  
MYRM312 MYRM297 [pIcsAi677]	   This study	  
MYRM313 MYRM297 [pIcsAi716]	   This study	  
MYRM373 UT5600 [pJRD215 + pIcsA] This study 
MYRM374 UT5600 [pJRD215 + pBR322] This study 
MYRM378 UT5600 [pJRD215 + pIcsAI633] This study 
MYRM379 UT5600 [pJRD215 + pIcsAI643] This study 
	   36	  
MYRM380 UT5600 [pJRD215 + pIcsAI677] This study 
MYRM381 UT5600 [pJRD215 + pIcsAI716] This study 
MYRM578 UT5600 [pRMA154 + pIcsA] This study 
MYRM383 UT5600 [pRMA154 + pBR322] This study 
MYRM387 UT5600 [pRMA154 + pIcsAI633] This study 
MYRM388 UT5600 [pRMA154 + pIcsAI643] This study 
MYRM389 UT5600 [pRMA154 + pIcsAI677] This study 
MYRM390 UT5600 [pRMA154 + pIcsAI716] This study 
MYRM522 RMA2041 degP::CmR This study 
MYRM675 MYRM522 [pIcsA] This study	  
MYRM525 MYRM522 [pIcsAi716] This study	  
MYRM526 MYRM522 [pBR322] This study	  
MYRM734 RMA2090 [pMYRM718] This study 
MYRM721 RMA2107 [pMYRM718] This study 
MYRM722 KMRM147 [pMYRM718] This study 
MYRM723 MYRM277 [pMYRM718] This study 
MYRM724 RMA2107 [pACYC184] This study 
MYRM725 MYRM289 [pACYC184] This study 
MYRM726 MYRM275 [pACYC184] This study 
MYRM727 MYRM276 [pACYC184] This study 
MYRM728 MYRM277 [pACYC184] This study 
MYRM729 RMA2107 [pRMA727] This study 
MYRM730 MYRM289 [pRMA727] This study 
MYRM731 MYRM275 [pRMA727] This study 
MYRM732 MYRM276 [pRMA727] This study 
MYRM733 MYRM277 [pRMA727] This study 
Plasmids   
pACYC184 Low copy number; P15A ori; TcR, CmR  NEB 
pBAD33 Arabinose-inducible pBAD promoter vector; CmR (Guzman et al., 1995) 
pBAD33::icsP icsP gene cloned into pBAD33; CmR This study 
pBR322 Medium copy no.; ColE1 ori; ApR, TcR (Bolivar et al., 1977) 
pIcsA icsA gene cloned into pBR322; ApR (Van Den Bosch & 
Morona, 2003) 
pIcsAi633 pIcsA with 5 amino acids insertion at aa633; ApR (May & Morona, 2008) 
pIcsAi643 pIcsA with 5 amino acids insertion at aa643; ApR (May & Morona, 2008) 
pIcsAi677 pIcsA with 5 amino acids insertion at aa677; ApR (May & Morona, 2008) 
pIcsAi716 pIcsA with 5 amino acids insertion at aa716; ApR (May & Morona, 2008) 
pJRD215 Broad-host-range cosmid cloning vector; KmR, SmR; 
mob, plasmid mobilisation functions 
(Davison et al., 1987) 
pRMA154 pJRD215ClaI-Kpn1-pPM2213Cla1-Kpn1 KmR, SmR; 
encodes galF, rfb locus, rfc and gnd, Oag 
biosynthesis genes from S. flexneri 
(Morona et al., 1994) 
pKOK6.1 Derivative of pKOK6 with inverse direction of the 
lacZ/Kan cassette in pKOK6 and has additional stop 
codons inserted into upstream of lacZ via the BamHI 
site; CmR, KmR 
(Kokotek & Lotz, 
1989; Murray et al., 
2003)  
pQE60 Expression vector with a C-terminal His6 tag; ApR Qiagen 
pQE60::icsP icsP gene cloned into pQE60; ApR This study 
pRMA727 rmlD (rfbD) gene cloned into pACYC184; CmR (Van Den Bosch et 
al., 1997) 
pSU23 Medium copy no.; P15A ori; CmR (Bartolome et al., 
1991) 
pMYRM632 icsA promoter region transcriptionally fused to lacZ-
Km; ApR, CmR, KmR 
This study 
pMYRM676 Derived from pMYRM632 with a stop codon inserted 
between icsA and lacZ; ApR, CmR, KmR	   This study 
pMYRM718 PstI-SalI fragment containing icsA promoter-TGA- This study 
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lacZ-Km derived from pMYRM676, cloned into 
pSU23; CmR, KmR 
   
# TcR, Tetracycline resistant; KmR, Kanamycin resistant; ApR, Ampicillin resistant; CmR, Chloramphenicol 888	  
resistant; SmR, Streptomycin resistant. 889	  
 890	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Figure Legends 891	  
Figure 1. IcsAi expression and localisation in S-LPS and R-LPS S. flexneri. (a) Whole 892	  
cell lysates from mid-exponential phase cultures of the indicated S. flexneri strains were 893	  
subjected to Western immunoblotting with anti-IcsA antibody. S= S-LPS; R = R-LPS. IcsA- 894	  
= IcsA deletion control. The 120 kDa band corresponds to the full length IcsA and the 85 895	  
kDa band corresponds to the cleaved form (IcsA’). (b) IF microscopy to detect IcsAWT or 896	  
IcsAi surface distribution. Mid-exponential phase cultures of the indicated S. flexneri 897	  
strains were formalin fixed and labelled with anti-IcsA antibody and then goat anti-rabbit 898	  
Alexa Fluor-488 secondary antibody. The while arrow indicates S-LPS S. flexneri 899	  
expressing low levels of IcsAi716 (KMRM147). Scale bar = 10 µm.  900	  
 901	  
Figure 2. rmlD complemented S. flexneri strains expressing IcsAWT or IcsAi. Whole 902	  
cell lysates from mid-exponential phase cultures of indicated the S. flexneri strains were 903	  
prepared as described in the Methods. (a) LPS samples (equivalent to 1 x 109 bacteria) 904	  
were prepared, electrophoresed on a SDS-15%-PAGE gel and silver stained as described 905	  
in the Methods. (b) Whole cell lysates were electrophoresed on a SDS-12%-PAGE gel and 906	  
subjected to Western immunoblotting with anti-IcsA antibody. 907	  
 908	  
Figure 3. LPS depletion-regeneration assay. Mid-exponential phase S-LPS S. flexneri 909	  
expressing IcsAWT or IcsAi716 were treated with 10 µg tunicamycin mL-1 or DMSO and 3 µg 910	  
polymyxin B nonapeptide mL-1 (PMBN) for 3 h at 37°C, followed by removal of 911	  
tunicamycin/PMBN/DMSO and allowed to grow for another 3 h to regenerate LPS Oag as 912	  
described in the Methods. (a) LPS samples (equivalent to 1 x 109 bacteria) were prepared, 913	  
electrophoresed on a SDS-15%-PAGE gel and silver stained as described in the Methods. 914	  
U = Untreated; D = Degeneration phase; R = Regeneration phase. (b) Whole cell lysates 915	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were electrophoresed on a SDS-12%-PAGE gel, and subjected to Western 916	  
immunoblotting with anti-IcsA antibody. 917	  
 918	  
Figure 4. Effect of IcsP on IcsAi production levels. (a) Tricholoroacetic acid-919	  
precipitated culture supernatants from mid-exponential phase cultures of the indicated S. 920	  
flexneri strains. P = Whole cell lysates; SN = Supernatant. (b, c) Mid-exponential phase 921	  
cultures of the indicated S. flexneri strain expressing IcsAWT or IcsAi mutants were treated 922	  
with 0.2% (w/v) L-arabinose to induce IcsP expression as described in the Methods. 923	  
Whole cell lysates were prepared, electrophoresed on a SDS-12%-PAGE gel and 924	  
subjected to Western immunoblotting with anti-IcsA and anti-IcsP. (b) Western blot 925	  
analysis of IcsAi mutant and IcsP expression in virulence plasmid-cured S-LPS strain. (c) 926	  
Western blot analysis of IcsAi mutant and IcsP expression in virulence plasmid-cured R-927	  
LPS strain. The positions of the bands corresponding to IcsA, IcsA’ and IcsP are shown. 928	  
 929	  
Figure 5. β-galactosidase assay on S-LPS and R-LPS S. flexneri strains. S-LPS and 930	  
R-LPS S. flexneri strains expressing IcsAWT, S-LPS and R-LPS S. flexneri strains 931	  
expressing IcsAi716 that are carrying pSU23-PicsA-TGA-lacZ were grown to mid-932	  
exponential phase at 37°C and the β-galactosidase activity was measured as described in 933	  
the Methods. Data represent the means of three independent experiments. Error bars 934	  
represent standard error of the mean (*P < 0.05). S-LPS IcsAWT = MYRM734; R-LPS 935	  
IcsAWT = MYRM721; S-LPS IcsAi716 = MYRM722; R-LPS IcsAi716 = MYRM723. 936	  
 937	  
Figure 6. IcsA production in S. flexneri degP::Cm ΔicsA. Whole cell lysates from mid-938	  
exponential phase cultures (grown at 30°C or 37°C) of the indicated S. flexneri strains 939	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were electrophoresed on a SDS-12%-PAGE gel and subjected to Western immunoblotting 940	  
with anti-IcsA antibody. 941	  
 942	  
Figure 7. N-WASP recruitment and F-actin comet tail formation by intracellular S-943	  
LPS and R-LPS S. flexneri strains. HeLa cells infected with S. flexneri expressing 944	  
IcsAWT, IcsAi677 or IcsAi716 were labelled with anti-N-WASP and Alexa Fluor 594-945	  
conjugated donkey anti-rabbit secondary antibody (red) to detect N-WASP, F-actin was 946	  
labelled with Alexa Fluor 488-phalloidin (green), HeLa cells and bacteria was labelled with 947	  
DAPI (blue) as described in the Methods. Strains were assessed in two independent 948	  
experiments. Arrows indicate N-WASP recruitment and F-actin comet tail formation. Insert 949	  
shows an enlarged view for greater clarity. Scale bar = 10 µm. 950	  
 951	  
Figure 8. Trypsin accessibility of IcsAi mutants. Mid-exponential phase cultures of the 952	  
indicated R-LPS S. flexneri strains expressing IcsAWT or IcsAi mutants were treated with 953	  
0.1 µg trypsin mL-1 at 25°C. Aliquots were taken at 0 min, 5 min, 15 min and 20 min and 954	  
supplemented with 1 mM phenylmethylsulphonylfluoride (PMSF) to inhibit further 955	  
proteolysis. Whole cell lysates were electrophoresed on a SDS-12%-PAGE gel and 956	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 Table S1. Oligonucleotides used in this study 
 
 
# Underlined and bolded sequences indicate the nucleotides that undergo site-directed mutagenesis 
‡ Contact authors for the DNA sequence 





Primer Oligonucleotide sequence (5’ – 3’) # Target Nucleotide positions 
lacZ_TGA_F tcttccaacccctctcatgcatgaggggctagaga IcsA-TGA-lacZ -  ‡ 
lacZ_TGA_R tctctagcccctcatgcatgagaggggttggaaga IcsA-TGA-lacZ -  ‡ 
ET9 ggccatggacatttcaaccaaaaaag icsP 220267 § 
ET10 gcggatccaaaaatatactttatacctgcg icsP 221244 § 
ET22 gcggtaccataaagtaagaagatcatggac 16bp upstream icsP 220251 § 
ET25 gggaagctttcaaaaaatatactttatacctg icsP 221247 § 
